Last reviewed · How we verify

NCT05161273

Risk Factors for Lower Extremity Overuse Injuries in Jump-landing Athletes

Completed Last updated 26 August 2024
What this trial tests

trial in Landing Biomechanics in 150 participants. Completed in 20 August 2024.

Timeline
1 June 2021
Primary endpoint
1 August 2022
20 August 2024

Quick facts

Lead sponsorUniversity Ghent
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date1 June 2021
Primary completion1 August 2022
Estimated completion20 August 2024
Sites1 location across Belgium

Conditions studied

Sponsor

University Ghent

Who can join

Adults 18 to 65, male only, with Landing Biomechanics or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective study, male jump-landing athletes (volleyball and basketball) will be screened pre-season and followed for one consecutive season. Pre-season screening consists of 3D biomechanical analysis of standardized (such as drop vertical jump) and sports-specific jumps (such as stop-jump) before and after a high-intensity, intermittent exercise protocol and clinical field tests (such as force measurements).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of Jump-Landing Biomechanics during and after Fatigue: Investigation on the Optimal Timing of Screenings under Fatigue.
    Vermeulen S, Bleecker C, Spanhove V, Segers V, et al · · 2025 · PMID 41245975 · DOI 10.5114/jhk/200421

Verify or expand the search:

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05161273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing